Closing in on a vaccine for breast cancer

Mammograms could more frequently bear good news if researchers develop an effective breast cancer vaccine.Progress toward development of a breast cancer vaccine has been reported by researchers at Washington University School of Medicine and the Siteman Cancer Center in St. Louis. Physicians believe a vaccine-induced immune response could be used to supplement other cancer therapies or to immunize high-risk people against cancer.

Preventing neonatal respiratory distress syndrome

WUSM researchers have developed new risk estimates for premature babies.If a woman goes into labor before her baby is full term, her obstetrician must make a crucial recommendation: delay labor or allow it to continue. Delivering the baby prematurely may increase the risk of neonatal respiratory distress syndrome (RDS), a potentially fatal condition. Now medical researchers at Washington University in St. Louis have generated new risk estimates for RDS that allow physicians to make delivery decisions with far greater confidence.

Sequenced parasite tells more about pathogen’s dirty work

Michael R. Brent and Tamara L. Doering examine data from the *C. neoformans* microarray.A team of collaborators, including two researchers from Washington University in St. Louis, has sequenced the genomes of two strains of the fungus Cryptococcus neoformans (C. neoformans), one which is virulent, the other harmless. This work provides researchers with clues on how the fungus does its dirty work and a host of genes to study for a better understanding of fungal pathogens in general. Estimates are that about 15 percent of people with HIV will suffer at least one life-threatening infection of C. neoformans. In Africa, that could be as much as 40 percent of HIV sufferers.
View More Stories